1-s2.0-s1357272518300840-main.pdf (686.47 kB)
Urinary extracellular vesicle biomarkers in urological cancers: From discovery towards clinical implementation
journal contribution
posted on 2018-09-10, 12:54 authored by Bert DhondtBert Dhondt, Jan Van Deun, Silke Vermaerke, Ario de Marco, Nicolaas Lumen, Olivier De Wever, An HendrixUrine contains cellular elements, biochemicals, and proteins derived from glomerular filtration of plasma, renal tubule excretion, and urogenital tract secretions that reflect an individual's metabolic and pathophysiologic state. Despite intensive research into the discovery of urinary biomarkers to facilitate early diagnosis, accurate prognosis and prediction of therapy response in urological cancers, none of these markers has reached widespread use. Their implementation into daily clinical practice is hampered by a substantial degree of heterogeneity in performance characteristics and uncertainty about reliability, clinical utility and cost-effectiveness, in addition to several technical limitations. Extracellular vesicles (EV) have raised interest as a potential source of biomarker discovery because of their role in intercellular communication and the resemblance of their molecular content to that of the releasing cells. We review currently used urinary biomarkers in the clinic and attempts that have been made to identify EV-derived biomarkers for urological cancers. In addition, we discuss technical and methodological considerations towards their clinical implementation.
History
Usage metrics
Categories
- Oncology and carcinogenesis not elsewhere classified
- Biochemistry and cell biology not elsewhere classified
- Genomics
- Other biomedical and clinical sciences not elsewhere classified
- Plant cell and molecular biology
- Animal cell and molecular biology
- Pathology (excl. oral pathology)
- Oral medicine and pathology
- Animal physiology - biophysics
- Animal physiology - cell
- Animal physiology - systems
- Protein trafficking
- Signal transduction
- Analytical spectrometry
- Sensor technology (incl. chemical aspects)
- Medical biochemistry and metabolomics not elsewhere classified
- Cancer cell biology
- Cancer diagnosis
- Cancer genetics
- Cell physiology
- Health care administration
- Medical biochemistry - lipids
- Medical biochemistry - nucleic acids
- Medical biochemistry - proteins and peptides (incl. medical proteomics)
- Solid tumours
Keywords
BiomarkersOmicsExtracellular vesiclesExosomesUrineCancerCancerCell BiologyGenomicsMedicineMolecular BiologyPathologyPhysiologyProtein TraffickingSignal TransductionBiochemistryAnalytical SpectrometrySensor Technology (Chemical aspects)BiomarkersCancer Cell BiologyCancer DiagnosisCancer GeneticsCell PhysiologyHealth CareMedical Biochemistry: LipidsMedical Biochemistry: Nucleic AcidsMedical Biochemistry: Proteins and Peptides (incl. Medical Proteomics)Solid Tumours
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC